Protein detail

RECK

Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein)

Entry name
RECK
UniProt ID
EVMP confidence score
0.72
Supporting publications (n)
13
Transmembrane count
Protein classification
Plasma proteinsPredicted membrane proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information10
Protein Names
Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein)
Protein Class (2)
Plasma proteinsPredicted membrane proteins
Entrez Gene Symbol
Gene Synonym (2)
hRECKST15
Gene Description
Reversion inducing cysteine rich protein with kazal motifs
Chromosome
9
Position
36036913-36124455
Supporting publications (n)
13
EVMP confidence score
0.72
Fluorescence & Localization3
RECK fluorescence
Cell SpecificAlveolar cells type 1Single-Nuclei Brain Specificleukocyte
Function & Pathway6
Relations & Evidence22

Ligand-Receptor Signaling (20)

20 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorICELLNETNoYesNoYesYes
receptorreceptorCellTalkDBNoYesNoYesYes
wnt_pathwayreceptorICELLNETNoYesNoYesYes
receptorreceptorOmniPathNoYesNoYesYes
cell_adhesioncell_adhesionCellinkerYesYesNoYesYes
adhesionadhesionOmniPathYesYesNoYesYes
cell_adhesioncell_adhesionOmniPathYesYesNoYesYes
transmembranetransmembraneTopDBNoNoNoYesYes
transmembranetransmembraneRamilowski_locationNoNoNoYesYes
transmembranetransmembraneOmniPathNoNoNoYesYes
Page 1 of 2Next

Protein Complex Composition (1)

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
RECKWLSWNT7AO00755O95980Q5T9L31:1:1PDBPDB:8tzp

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry140326690
Sequence, Structure & Domains11

Sequences

Length
971
Mass
106,457
Sequence
MATVRASLRGALLLLLAVAGVAEVAGGLAPGSAGALCCNHSKDNQMCRDVCEQIFSSKSESRLKHLLQRAPDYCPETMVEIWNCMNSSLPGVFKKSDGWVGLGCCELAIALECRQACKQASSKNDISKVCRKEYENALFSCISRNEMGSVCCSYAGHHTNCREYCQAIFRTDSSPGPSQIKAVENYCASISPQLIHCVNNYTQSYPMRNPTDSLYCCDRAEDHACQNACKRILMSKKTEMEIVDGLIEGCKTQPLPQDPLWQCFLESSQSVHPGVTVHPPPSTGLDGAKLHCCSKANTSTCRELCTKLYSMSWGNTQSWQEFDRFCEYNPVEVSMLTCLADVREPCQLGCRNLTYCTNFNNRPTELFRSCNAQSDQGAMNDMKLWEKGSIKMPFINIPVLDIKKCQPEMWKAIACSLQIKPCHSKSRGSIICKSDCVEILKKCGDQNKFPEDHTAESICELLSPTDDLKNCIPLDTYLRPSTLGNIVEEVTHPCNPNPCPANELCEVNRKGCPSGDPCLPYFCVQGCKLGEASDFIVRQGTLIQVPSSAGEVGCYKICSCGQSGLLENCMEMHCIDLQKSCIVGGKRKSHGTSFSIDCNVCSCFAGNLVCSTRLCLSEHSSEDDRRTFTGLPCNCADQFVPVCGQNGRTYPSACIARCVGLQDHQFEFGSCMSKDPCNPNPCQKNQRCIPKPQVCLTTFDKFGCSQYECVPRQLACDQVQDPVCDTDHMEHNNLCTLYQRGKSLSYKGPCQPFCRATEPVCGHNGETYSSVCAAYSDRVAVDYYGDCQAVGVLSEHSSVAECASVKCPSLLAAGCKPIIPPGACCPLCAGMLRVLFDKEKLDTIAKVTNKKPITVLEILQKIRMHVSVPQCDVFGYFSIESEIVILIIPVDHYPKALQIEACNKEAEKIESLINSDSPTLASHVPLSALIISQVQVSSSVPSAGVRARPSCHSLLLPLSLGLALHLLWTYN

3D Structural Models

Helix
211..218; 223..235; 239..249; 259..269
3D Structure
Electron microscopy (1)

Domain & Motif Annotations

Repeat
37..84; Knot 1; 104..141; Knot 2; 151..197; Knot 3; 216..263; Knot 4; 292..338; Knot 5
Domain (CC)
The Kazal-like domains mediate the serine protease inhibitor activity.
Domain (FT)
627..673; Kazal-like 1; 698..752; Kazal-like 2; 753..789; Kazal-like 3
Region
37..338; 5 X Knot repeats
Protein Families
RECK family
Sequence Similarities
Belongs to the RECK family.
Clinical Relevance2
Disease Involvement
Tumor suppressor
Supporting Publications13
PMIDTitleAbstract
39207047The trajectory of vesicular proteomic signatures from HBV-HCC by chitosan-magnetic bead-based separation and DIA-proteomic analysis.No abstract available
40189497Small extracellular vesicle-based one-step high-throughput microfluidic platform for epithelial ovarian cancer diagnosis.No abstract available
41068253Identification of plasma extracellular vesicle protein biomarkers in diabetic retinopathy progression.No abstract available
Page 2 of 2Previous